Delivery Order SPE2DB20D2104-SPE2DB22FS63W
Award Date 5/5/22
Potential Completion Date 5/6/22
Potential Value $2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $12,786.49 Firm Fixed Price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 22, 2022 with a completion date of June 23, 2022. This order is associated with AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $5,053.11, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 21, 2021. The contract is a firm fixed-price delivery order with a completion date of December 22, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $3,326.76 and a completion date of January 26, 2022. The award was made on January 25, 2022, and there was no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion from Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,320.58 delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of January 28, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,482.88 and was awarded on June 6, 2022, with a completion date of June 7, 2022. The contract is a delivery order with a firm fixed price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a ceiling value of $8,729.62 and a completion date of October 20, 2021. The contract was awarded on October 19, 2021, and there was no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract, valued at $15,912.49, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 5, 2023. This is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,350.60 and was awarded on February 1, 2022, with a completion date of February 2, 2022. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The $2,557.08 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion 30s to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $10,105.84 and was awarded on March 10, 2022, with a completion date of March 11, 2022. The contract is a firm fixed-price delivery order, with no set-aside designations. Amerisourcebergen Drug Corp is a...